Sino Biopharm Buys siRNA-Focused Hygieia In Cardiovascular Drive

Acquired
Sino Biopharm is buying out Hangzhou Hygieia Biomedical, a Chinese small interfering RNA specialist. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business